In this timely study, SHP's Lee Sanders reveals that Medicaid discharges accounted for $119.5 billion—more than half of all pediatric hospital discharges nationwide—a figure the researchers called “striking.”
Stanford Law’s Michelle Mello—also a professor of health policy—discusses how sweeping changes in federal health policy are reshaping public health—and leading states to fill the void.
SHP researchers built a model to test whether AI could beat traditional methods to stop disease spread between prisons and nearby communities. The verdict was clear.
A working paper that the longtime Stanford health economist drafted more than 35 years ago tying child-care subsidies to women’s economic equality sees the light of day.
Previous studies found coronary artery bypass grafting (CABG) to be cost-effective compared with percutaneous coronary intervention (PCI), but new research led by SHP's Mark Hlatky shows their comparative effectiveness and economic outcomes may have changed.
Global conflicts, infectious diseases, natural disasters driven by climate change, and increases in the number of refugees worldwide, are magnifying the need for humanitarian services at a time of increasingly constrained humanitarian resources.
SHP's Michelle Mello joins a global group of 65 thought leaders from academia, technology companies, regulatory agencies, and health systems dissected and debated actionable solutions to effectively, safely, and responsibly deploy AI into clinical practice.
Colleagues joined the Stanford professor of health policy at the annual AOM conference to praise Singer for the wide scope of her research and contributions on how organizations can producer higher quality and safer care.
The manhunt and arrest of the suspected murderer of UnitedHealthcare's CEO fueled a viral media circus that proved irresistible for some Bay Area comics, including Stanford Health Policy PhD candidate Nova Bradford.
Stanford ophthalmology faculty, residents, and medical students are working to provide low-cost screening and treatment for blind babies across sub-Saharan Africa. Among those leading the way is SHP Rosenkranz Prize Winner Arthur Brant.
Although 58% of Americans rely on employer-sponsored health insurance, U.S. corporations are doing surprisingly little to improve health-care options for their employees, according to research by Graduate School of Business Professors Jeffrey Pfeffer and Sara Singer.
Stanford researchers address a persistent flaw in the U.S. health system: prioritizing treatment investment based on market potential rather than medical necessity.
In this commentary, Ruth Gibson and Gary Darmstadt argue that academics can help shape sanctions policy by suggesting ways to reduce humanitarian harm.
To help health care leaders and clinicians navigate the thorny terrain of using artificial intelligence (AI) tools in their testing and care, SHP's Michelle Mello and colleagues provide a framework for deciding what patients should be told about AI tools.
On the World Class Podcast, Ruth Gibson shares sobering new data with Michael McFaul about the adverse impact the cessation of foreign aid can have, especially on women and children.
